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Despite nerve-sparing radical prostatectomy, nerve dam-
age and erectile dysfunction (ED) prevail, and preventing
neurodegeneration is of great importance. Neurotrophic
factors and neurite outgrowth were characterized in major
pelvic ganglia (MPG) following bilateral cavernous nerve
injury (BCNI). Young male Sprague-Dawley rats under-
went sham or BCNI surgery, and the intracavernosal
pressure to mean arterial pressure ratio was measured 2,
7, 14, 21, 30, and 60 days following injury (n58/group).
MPG gene expression (qPCR) and Western blot were per-
formed for glial cell line-derived neurotrophic factor
(GDNF), nerve growth factor (NGF), neurturin, neurotro-
phin (NT)23, NT4, brain-derived neurotrophic factor
(BDNF), vascular endothelial growth factor, and activating
transcription factor 3 (ATF3). Additional rats were injured,
and MPGs were removed 24 hr, 48 hr, 3 days, and 7 days
following BCNI (n5 3/group). MPGs were cultured in
Matrigel, and neurite outgrowth was measured. Erections
were impaired early and improved by 60 days in BCNI
rats. GDNF, NGF, BDNF, and ATF3 gene expression was
significantly increased and NT3 was decreased in MPGs
following BCNI (48 hr to 21 days, P< 0.05). GDNF and
NGF protein levels were elevated in 48-hr BCNI rats.
MPG neurite outgrowth from 24-hr and 48-hr BCNI was
higher than sham (658619 lm, 607624 lm, 3936 23
lm, respectively, P<0.05). Further studies examining the
roles of neurotrophic factors in modulating signaling path-
ways may provide therapeutic avenues for neurogenically
mediated ED. VC 2015 Wiley Periodicals, Inc.
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The major pelvic ganglia (MPG) are peripheral mixed
ganglia consisting of sympathetic and parasympathetic neu-
rons that innervate the urogenital organs and the lower gas-
trointestinal tract. The location of the ganglia and
cavernous nerve (CN), they are susceptible to neuropraxia
or neurectomy during pelvic surgeries, such as radical pros-
tatectomy (RP), which can result in neurogenic complica-
tions, including urinary incontinence and erectile
dysfunction (ED; Boorjian et al., 2012). To limit this func-
tional consequence of pelvic surgery, so-called nerve-spar-
ing operative techniques have been developed in an
attempt to limit nerve damage to neuropraxia, in which
spontaneous nerve recovery without surgical nerve realign-
ment is a realistic expectation. To improve erectile function
outcomes of RP surgeries further, studies have focused on
pharmacological therapies, such as phosphodiesterase 5
inhibitors, to limit end organ damage in the penis, without
any success (Montorsi et al., 2014; Pisansky et al., 2014).
To develop effective interventions to prevent neurodegen-
eration and promote neuroregeneration, a better under-
standing of the intrinsic processes that take place within the
injured MPG and CN is required.
The peripheral nervous system has demonstrated the
ability to regenerate and sprout new axons after injury,
although many factors contribute to the functional out-
come. The severity and type of nerve injury, age, or
underlying diseases will impact repair and recovery
(Scheib and Hoke, 2013). After injury, distal nerves
undergo Wallerian degeneration, and a regenerative
response is initiated in the neuronal cell bodies (expres-
sion of regeneration-associated genes) and in Schwann
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cells (upregulation of neurotrophins, cytokines, chemo-
kines, and extracellular matrix proteins; Kiryu-Seo and
Kiyama, 2011; Scheib and Hoke, 2013). In sciatic nerve
injury, neurotrophic factors such as glial cell line-derived
neurotrophic factor (GDNF), brain-derived neurotrophic
factor (BDNF), nerve growth factor (NGF), and neuro-
trophin (NT)-3 are produced in a temporal fashion to
encourage axon growth (Golz et al., 2006). These proc-
esses in the MPG are now being studied; however, they
are not well defined or have been assessed at only one
time point following injury.
To determine the temporal gene expression changes
that occur in the MPG following injury, we assessed
global gene expression changes in injured MPGs at early
(48 hr) and later (14 days) time points. Many significant
changes were evident at a transcriptional level involving
galanin, GDNF, BDNF, and NGF signaling pathways
(Calenda et al., 2012; Weyne et al., 2014). Additionally,
exogenous neurotrophic therapies have been used to pro-
mote erectile recovery in diabetic or CN injury rat mod-
els of ED. These investigations provide support for the
use of neurotrophic factor therapy but have not fully
addressed the pathogenesis of CN dysfunction that occurs
in the MPG to promote neuritogenesis and regeneration.
In addition to the CN injury rat model of ED, the
MPG can be excised and grown on Matrigel to access its
ability to sprout and grow neurites. This is an experimental
tool that can be used to access the ability of different com-
pounds to inhibit or promote MPG neurite growth. Neu-
rite outgrowth in explanted MPGs grown in culture is
dependent on neurotrophic factor stimulus (Lin et al.,
2003; Bella et al., 2006; Lin et al., 2006). In general, neuro-
trophic factors alone or in combination have been shown
to enhance MPG neurite outgrowth in young and old
MPGs (Lin et al., 2010). MPG Matrigel culture following
CN injury has yet to be assessed. In dorsal root ganglia
(DRG) culture, in vivo sciatic nerve injury leads to twice
the length of DRG neurite outgrowth compared with
uninjured DRG (Aguis et al., 1998). Injury can prime the
nerves for outgrowth by upregulating intrinsic growth fac-
tors to allow for repair and regeneration. We sought to
determine whether the increased gene expression of neuro-
trophic factors seen in vivo following CN injury could
impact the neurite outgrowth of the MPG in vitro.
This study examines the time course of intrinsic neuro-
trophic factors from the GDNF and NGF families in the
MPG following a moderate CN crush injury. The degree of
injury was assessed by measuring a marker of nerve injury,
activating transcription factor 3 (ATF3), and recording erec-
tile function. Additionally, we assessed the time course of
neurite outgrowth in cultured control and CN-injured
MPGs to determine whether the intrinsic rise in neurotro-
phic factors could increase neurite outgrowth in MPGs.
MATERIALS AND METHODS
Animals and Experimental Design
Male Sprague Dawley rats (n5 119; Charles River,
Wilmington, MA) weighing 250–300 g were used in this study.
Rats had ad libitum access to standard rat chow and water. Rats
underwent sham (n5 16), or bilateral CN injury (BCNI) sur-
gery, and tissues were harvested 48 hr (BCNI 48-hr rats
n5 16), 7 days (BCNI 7-day rats n5 16), 14 days (BCNI 14-
day rats n5 16), 21 days (BCNI 21-day rats n5 8), 30 days
(BCNI 30-day rats n5 16), or 60 days (BCNI 60-day rats
n5 16) after injury to be used for molecular studies. Additional
rats underwent sham and BCNI surgeries, and MPGs were col-
lected 24 hr, 48 hr, 72 hr, or 7 days after injury and cultured in
Matrigel (n5 3/group). All experiments were conducted in
accordance with the Johns Hopkins University School of Medi-
cine guidelines for animal care and use, the NIH Guide for the
care and use of laboratory animals, and the Society of Neuroscience
guidelines for the use of animals in neuroscience and behavioral
research.
BCNI
With animals under isoflurane anesthesia, the prostate
was exposed via a midline laparotomy, and the MPG and
CN were identified bilaterally. In the BCNI groups, both
CNs were injured by crushing with forceps three times for
15 sec each 2–3 mm distal to the MPG (Hannan et al., 2013,
2014). Adequate crush was confirmed by an observable
change in nerve color to gray, with the neurolemma remain-
ing intact. In sham animals, the CN was identified, and the
abdomen was closed. BCNI surgeries were all performed by
the same surgeon.
Measurement of Erectile Responses
With animals under anesthesia, the right CN was identi-
fied. The right cru was cannulated with a 25-G needle con-
nected to a pressure transducer to measure intracavernous
pressure (ICP). The right carotid artery was cannulated for con-
tinuous measurement of mean arterial pressure (MAP). The
CN distal to the crush injury was stimulated with a square pulse
stimulator (Grass Instruments, Quincy, MA) at a frequency of
20 Hz, duration of 0.5 msec, and pulse width of 30 sec at
increasing voltages (2, 4, 6, and 8 V) for 1 min, with 3–5 min
between stimulations. The ratio between maximal ICP and
MAP obtained at the peak of erectile response was calculated to
normalize for variations in systemic blood pressure. Total ICP
was measured as the area under the curve (AUC) during the
time of stimulation.
Major Pelvic Ganglia Culture and Neurite Outgrowth
Assessment
After sham or BCNI surgeries, MPGs were carefully dis-
sected at 24 hr, 48 hr, 72 hr, or 7 days after injury to be cul-
tured in Matrigel (n5 3/group). Whole MPGs were carefully
separated from the prostatic capsule, excised, and kept on ice in
serum-free media (RPMI 1640 with 1% penicillin–streptomy-
cin; Gibco, Grand Island, NY) until they were embedded.
Reduced growth factor Matrigel was diluted with media, and
200 ml was placed on the bottom of a 24-well plate. After poly-
merization, MPGs were placed in the center of the well, cov-
ered with 300 ml diluted Matrigel, and allowed to harden for 30
min at 37C. MPGs were covered with 1 ml media with
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vascular endothelial growth factor (VEGF; 25 mg/ml; R&D
Systems, Minneapolis, MN), which was changed every 24 hr
and maintained at 37C in a humidified atmosphere with 5%
CO2. Photographs of neurite growth at 24, 48, and 72 hr were
captured with a Nikon TE200 inverted microscope attached to
a CCD camera, and digital images were analyzed in Elements
software (Nikon Instruments, Melville, NY). In each area of
growth from the MPG, the five longest neurites were meas-
ured. The averages of these measurements defined the neurite
length for groups at each time point (20–25 neurites measured
per MPG).
Quantitative PCR
Real-time quantitative PCR (qPCR) was used to deter-
mine relative expression of neurotrophic factors in MPGs from
sham, 48-hr, 7-day, 14-day, 21-day, 30-day, and 60-day BCNI
rats. Frozen MPGs were homogenized, and total RNA was puri-
fied with the RNeasy system (Qiagen, Hilden, Germany), quan-
tified, and then reverse transcribed with Ready-To-Go You-
Prime first-strand beads (GE Healthcare, Pittsburgh, PA). Real-
time qPCR was performed with the StepOnePlus system
(Applied Biosystems, Foster City, CA). TaqMan gene expression
assays for GDNF (Rn00569510), VEGF (Rn01511601), BDNF
(Rn02531967), neurturin (NRTN; Rn01527513), NGF
(Rn01533872), NT3 (Rn00579280), NT4 (Rn00566076),
ATF3 (Rn00563784), and hypoxanthine phosphoribosyltransfer-
ase 1 (HPRT1; Rn01527840) were used. HPRT1 was
unchanged between groups and served as an endogenous control
in which all values were normalized to HPRT1 transcript levels
(Applied Biosystems). All experiments were performed on eight
separate whole MPG cellular fractions from each group with
triplicate technical replicate PCRs per sample.
Western Blot Analysis
Whole, paired MPGs (n5 8/group) were excised from
sham, 48-hr, 7-day, 14-day, 30-day, and 60-day BCNI rats and
homogenized in cell lysis buffer (Cell Signaling Technology,
Beverly, MA). Cellular fractions from homogenized MPGs were
isolated for GDNF and NGF Western blot analysis. Protein
amounts were determined with the BCA kit (Pierce, Rockford,
IL), and equal amounts of protein (30 mg) were loaded onto 4–
20% Tris-HCl gel (Bio-Rad, Hercules, CA). After their separa-
tion by SDS-PAGE, the proteins were transferred to polyvinyli-
dene fluoride membranes and incubated with primary antibodies
(GDNF 1:200, NGF 1:200, and glyceraldehyde-3-phosphate
dehydrogenase [GAPDH] 1:2,000; Santa Cruz Biotechnology,
Santa Cruz, CA) overnight at 4C. The membranes were incu-
bated with a horseradish peroxidase-linked secondary antibody
and visualized with an enhanced chemiluminescence kit (Amer-
sham Biosciences, Piscataway, NJ). The densitometry results
were normalized by GAPDH expression, which was unchanged
between groups. The intensities of the resulting bands were
quantified in ImageJ (NIH, Bethesda, MD).
Statistical Analysis
Data are expressed as mean6 SEM. Differences between
multiple groups were compared by one-way ANOVA, fol-
lowed by Tukey’s multiple-comparisons test (GraphPad Prism
5; GraphPad Software, San Diego, CA). ATF3, GDNF, and
NGF expression and ICP/MAP values from sham and all
BCNI time points were correlated by calculating Spearman’s




Erectile function was significantly lower at all time
points in a voltage-dependent manner following BCNI
(Fig. 1). At early time points after injury, a marked
decrease was demonstrated in both ICP/MAP and AUC,
which was lowest at 14 days. Erectile responses began to
increase gradually from 30 to 60 days following BCNI,
and at a stronger electrostimulation (6 V) 60-day injured
rats had significantly increased ICP/MAP compared with
BCNI 7–30-day rats (P< 0.05). Although erections were
improved at 60 days following BCNI, they remained sig-
nificantly lower than those in sham animals (P< 0.05).
These results are further illustrated in the representative
ICP and MAP tracings for each group (Fig. 1C).
Neurotrophic Factor Gene and Protein Expression
To confirm that the decrease in erectile response
was due to CN injury, we measured the gene expression
of a marker of neuronal injury, ATF3, in the MPG.
ATF3 was increased at all time points following BCNI;
however, it reached significance only at 48 hr, 14 days,
and 21 days postinjury (P< 0.05; Fig. 2A).
The gene expression of several neurotrophic factors
was assessed in the MPG following injury. BDNF gene
expression was significantly increased after 7 days
(P< 0.05) and had returned to sham values by 14 days
after BCNI (Fig. 2B). VEGF, a known vasculogenic
growth factor with neurotrophic properties, and NRTN,
a neurotrophic factor related to the GDNF family, were
not different following BCNI (Fig. 2C,D). NT3 and
NT4 are members of the NGF family of neurotrophic
factors. The gene expression of NT3 was significantly
decreased at early time points (48 hr and 7 days), was tem-
porarily increased at 14 and 21 days, and was lowered
again at 30 and 60 days following BCNI (P< 0.05; Fig.
2E). NT4 remained unchanged at all time points follow-
ing nerve injury (Fig. 2F).
The most pronounced change in neurotrophic fac-
tor gene expression following BCNI was GDNF. GDNF
mRNA increased 20-fold 48 hr after injury and
remained elevated five- to sevenfold up to 21 days post-
BCNI (P< 0.05; Fig. 3A). At later time points (30–60
days), GDNF gene expression was not different from
sham values. NGF gene expression was also significantly
elevated 48 hr, 14 days, and 21 days after crush injury
(P< 0.05) and returned to sham baseline at 30 and 60
days post-BCNI (Fig. 3B). Western blots were performed
for these two neurotrophic factors because they had the
most pronounced changes in gene expression. GDNF
protein amounts were significantly lower 48 hr following
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injury (P< 0.05) and at 7 days had returned to, and were
maintained at, sham levels (Fig. 3C). Similarly to GDNF,
NGF protein levels were significantly lower 48 hr follow-
ing injury and were normalized by 14 days post-BCNI
(Fig. 3D).
Correlation of Erectile Function and Neurotrophic
Factors
Erectile response data (ICP/MAP) recorded after 6-
V electrical stimulation were correlated with the corre-
sponding mRNA ATF3, GDNF, or NGF values. Spear-
man’s rank correlation coefficients between ATF3,
GDNF, and NGF gene expression and erectile responses
were 20.8264, 20.605, and 20.659, respectively
(P< 0.0001). ATF3 gene expression levels were signifi-
cantly increased when erectile responses were low, and
ATF3 mRNA levels were much lower when erections
had returned to sham levels (Fig. 4B). This strong nega-
tive correlation demonstrates that GDNF and NGF gene
expression values are high when erectile responses are
impaired.
Fig. 1. In vivo erectile responses. In vivo erectile responses were
assessed in sham and BCNI rats 48 hr and 7, 14, 30, and 60 days
(n5 8/group) after BCNI via electrostimulation of the cavernous
nerve. Bar graphs show voltage-dependent erectile responses, meas-
ured by the ICP to MAP ratio (A) and total ICP (area under the
erectile curve (B) after CNS for 1 min in all groups. Representative
tracing of ICP and MAP responses for each group are shown at 6-V
stimulation for 1 min, indicated by the solid bar along the x-axis (C).
Data are mean6 SEM. *P< 0.05 compared with sham rats; dP< 0.05
vs. BCNI 60-day rats.
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Neurite Outgrowth
The time course of neurite outgrowth was assessed
in MPGs cultured at 24 hr, 48 hr, 72 hr, and 7 days after
BCNI. Neurite outgrowth was measured after the MPGs
were incubated for 24, 48, and 72 hr. In all groups, neu-
rite outgrowth increased with incubation time (Fig. 5). A
significant increase in neurite growth was seen in MPGs
among rats injured 24 and 48 hr prior to culture com-
pared with sham MPGs (P< 0.05). BCNI 72-hr MPGs
grew less than sham MPGs after 24 hr of incubation but
were no different at 48 or 72 hr of incubation. MPGs that
had been injured 7 days prior to culture grew similarly to
sham MPGs after 24 and 48 hr; however, at 72 hr of
incubation, they showed significantly increased growth
vs. sham MPGs (P< 0.05).
DISCUSSION
This study demonstrates the temporal changes in neuro-
trophic factors in the injured MPG at early time points
when erections are severely diminished, reaching their
Fig. 2. Gene expression of neurotrophic factors. Bar graphs show MPG gene expression of ATF3
(A), BDNF (B), VEGF (C), NRTN (D), NT3 (E), and NT4 (F) from sham-operated rats and var-
ious time points from rats following BCNI (n5 8/group). The gene expression levels were normal-
ized to the gene expression level for GAPDH. Data are mean 6SEM. *P< 0.05 compared with
sham rats.
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lowest values after 14 days and beginning to improve by
30–60 days. The gene expressions of ATF3, GDNF,
NGF, and BDNF were temporally increased and NT3
was decreased at times when erectile function was
impaired. GDNF and NGF had the greatest increase in
MPG gene expression following CN injury. At later time
points, when erectile function was improved, all neuro-
trophic factors had returned to sham values. Neurite out-
growth from cultured MPGs was potentiated when the
MPG was harvested 24–48 hr after injury, indicating a
possible neuroregenerative effect of the observed early
ATF3 and neurotrophin upregulation.
We recently demonstrated a time course of sponta-
neous recovery of erectile function following BCNI with
ICPs stimulated at 8 V (Weyne et al., 2014). This study
uses the same time course following injury but demon-
strates the voltage responses from 2 to 6 V. Results similar
to ours were seen in BCNI mice that had a slight increase
in erectile function at 4 weeks and significant improve-
ments in erections at 8 and 12 weeks following injury (Jin
et al., 2010). Mice with CN transection demonstrated no
recovery of erections from 3 days to 12 weeks postinjury.
These data demonstrate the importance of evaluating
early and late time points to ensure that improvements in
erectile function following therapeutic interventions are
not due to intrinsic recovery of neuronal function.
ATF3 is an early gene upregulated in response to
injury (Tsujino et al., 2000) that enhances peripheral
nerve regeneration by promoting the growth of injured
neurons (Seijffers et al., 2007) and increases neuronal sur-
vival (Herdegen et al., 1997). After axotomy of the sciatic
nerve, ATF3 mRNA expression was significantly
increased within 12 hr of injury, was decreased slightly
after 6 weeks, and remained elevated in the DRG for 70
days (Tsujino et al., 2000). Explant cultured MPGs
expressed increased ATF3 mRNA 8 hr after being
Fig. 3. Gene and protein expression of GDNF and NGF. Bar graphs show MPG gene expression of
GDNF (A) and NGF (B) from sham-operated rats and various time points from rats following
BCNI (n5 8/group). GDNF and NGF gene expressions were normalized to relative expression of
GAPDH. Representative Western blots and bar graphs for GDNF (C) and NGF (D) protein
expression in MPGs from all groups. Data are normalized to GAPDH protein expression. Data are
mean6 SEM (n5 8/group). *P< 0.05 compared with sham rats.
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cultured, and transcript levels were elevated 84-fold after
3 days in culture (Girard et al., 2010). Our results are sim-
ilar to the crush-injured DRG results because there was a
significant increase in ATF3 gene expression at 48 hr, fol-
lowed by a decrease at 30 and 60 days. There was also a
very strong negative correlation between ATF3 transcript
levels and erectile function. Further studies are warranted
to determine its specific role in CN regeneration and
confirm whether it can serve as a marker of CN injury in
the MPG.
GDNF, which promotes the survival of central and
peripheral neurons, was determined to have the greatest
increase in MPG gene expression following injury (Trea-
nor et al., 1996). The expression of GDNF inversely cor-
related with erectile function. After CN transection, there
is a decrease in GDNF mRNA expression in the penis,
and GDNF protein undergoes retrograde transport from
the penis to the MPG (Laurikainen et al., 2000). The cur-
rent study provides evidence that GDNF is also produced
locally in the MPG to promote CN survival in an auto-
crine fashion. Increasing the expression of GDNF follow-
ing CN injury via herpes simplex viral (HSV) vector
delivery targeted to the MPG has been successful at
recovering erectile function (Kato et al., 2007).
Another member of the GDNF family that pro-
motes neuron growth and survival is NRTN. Although
we did not see any significant changes in the gene expres-
sion of NRTN in the injured MPG, many others have
reported its benefits for the treatment of neurogenic ED.
Extended release NRTN placed directly onto the MPG
following nerve crush leads to moderate improvement in
ICP responses 5 weeks after injury (Bella et al., 2007a).
NRTN HSV gene transfer also only mildly increased
erectile responses in CN injured rats (Kato et al., 2009).
Although NRTN appears to have had a modest beneficial
effect in both rat studies, erections were not recovered to
sham levels. The current data support these findings in
that NRTN was not activated in response to injury.
NGF was one of the first growth factors to be
described and was shown to increase growth of MPG cul-
tured neurons (Tuttle and Steers, 1992; Tuttle et al.,
1994). NGF was assessed as an in vivo treatment alone or
Fig. 4. Relationship between ATF3, GDNF, or NGF and erectile
responses. Dot plot shows the erectile responses, measured by the
ICP/MAP ratio after cavernous nerve stimulation at 6 V for 1 min in
sham, 48-hr, and 7-day, 14-day, 30-day, and 60-day BCNI rats (A).
Data are mean6 SEM (n5 8/group). Scatter diagrams show the rela-
tionship between MPG ATF3 (B), GDNF (C), or NGF (D) gene
expression level and ICP/MAP to cavernous nerve electrostimulation
at 6 V from sham and all injured time points. R, Spearman correlation
coefficient. *P< 0.05 ICP/MAP response compared with sham rats;
dP< 0.05 ICP/MAP response vs. BCNI 60-day rats.
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Fig. 5. Time course of MPG neurite outgrowth following injury.
Representative images of neurites sprouting from MPG from sham
animals in the presence of VEGF (B–D) cultured in vitro and the
methods of analysis (A). Images were all taken at 3100; arrows indi-
cate length of neurite. E: Bar graph shows neurite length of MPGs
from sham, 24-, 48-, and 72-hr and 7-day BCNI rats after 24, 48,
and 72 hr in culture. Data are mean6 SEM (n5 3/group). *P< 0.05
compared with sham rats at corresponding time points. [Color figure
can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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in combination with nerve grafts following CN ablation in
rats (Burger et al., 1991). Treatment with NGF alone mini-
mally increased erectile function, whereas in combination
with nerve grafts erections were restored (Burger et al.,
1991). The current findings show a correlation between
lower MPG NGF gene expression when neurogenic erec-
tile responses have improved. Additionally, NGF was
located primarily in the neuronal cell bodies and fibers in
the MPG. In peripheral nerves, NGF is transported in a ret-
rograde fashion from the target organ and promotes survival
(Zweidel et al., 2005). These data suggest that NGF is an
important growth factor in peripheral CN regeneration;
however, on its own, it may not be a potent enough
growth factor to recover neuronal function fully.
BDNF is an important neurotrophin that supports
survival of neurons by contributing to the growth, differ-
entiation, and maintenance of neurons. The protein
expression of BDNF in the MPG following crush or axot-
omy has been characterized at early time points (Bella
et al., 2007b; Bond et al., 2013). After axotomy, BDNF
protein levels and gene expression levels in the MPG were
increased after 1 and 5 days (Bella et al., 2007b); however,
after CN crush, BDNF was increased after 1 day, had
decreased to below sham levels by 4 days, and was normal-
ized after 7 days (Bond et al., 2013). The current results
indicate that BDNF gene expression is significantly
increased at 7 days and normalized at 14 days. In the rat,
overexpression of BDNF delivered intracavernosally via an
adeno-associated virus improved erectile responses 4 and 8
weeks following CN injury (Barkicioglu et al., 2001). It is
acknowledged that BDNF protein levels were not assessed
in the current study, and further investigation is warranted
to determine the role of BDNF in CN regeneration.
NT3, which is responsible for survival and growth
of new neurons, was the only neurotrophic factor assessed
that demonstrated significantly decreased gene expression
in the injured MPG. These results differ from results for
MPG gene expression of NT3 following CN axotomy, in
which NT3 was unchanged at 1 and 5 days (Bella et al.,
2007b). We did not see any changes in NT4 or VEGF
gene expression following BCNI. It is noteworthy that
most studies demonstrating success at increasing MPG
neurite growth in vitro or improving erectile function
have used these nerve growth factors in combination with
each other or BDNF (Hsieh et al., 2003; Lin et al., 2003).
Combination treatments in which BDNF and VEGF are
overexpressed have been successful at recovering erectile
function following CN injury by freezing and/or crush
(Hsieh, 2003; Chen, 2005). It is possible that preservation
of nerve function and prevention of neurodegeneration
will require a cocktail of nerve growth factors. Further-
more, based on our gene expression data, the timing of
administration of different growth factors might also be
critical for treatment.
Although we have demonstrated the time course of
gene expression of nerve growth factors following CN
injury, there is a disconnection between the transcrip-
tional regulation and the protein expression for GDNF
and NGF. One week after CN injury, GDNF and NGF
protein expression had returned to sham levels; however,
gene expression remained elevated up to 21 days. It is
possible that, although protein levels have normalized,
there are changes in specific neuron populations that
might account for the increased gene expression. After
CN axotomy, there was a greater decrease in MPG
immunofluorescent staining of GDNF family receptors in
parasympathetic vs. sympathetic neurons (Palma and
Keast, 2006). Future studies will serve to assess costaining
of nerve growth factors and markers of sympathetic, para-
sympathetic, and neuronal nitric oxide synthase-positive
neurons in sham and injured MPGs.
Neurite outgrowth from MPG neurons can be
stimulated by neurotrophic factors. To date, most studies
have looked at uninjured explanted MPGs. Prior injury to
a peripheral nerve is termed “conditioning” in DRGs and
has been shown to increase neurite growth (Smith and
Skene, 1997). We demonstrated that MPGs from animals
injured 24 or 48 hr prior to explant culture had the great-
est neurite outgrowth compared with intact MPGs. Addi-
tionally, MPGs from later injury time points (3 or 7 days)
did not demonstrate as much growth as the early injured
MPGs (24 or 48 hr). These results are in agreement with
the neurotrophic factor gene expression data, which was
highest 48 hr after BCNI and had decreased by 7 days
after BCNI. Additional studies are required to determine
whether there are changes in the sympathetic, parasympa-
thetic, and nitrergic types of neurites that grow in intact
vs. injured MPGs and to determine whether there is a dif-
ference in the response to growth factors.
One of the limitations to the current study is that
we do not have protein expression results for all of the
nerve growth factors that were assessed. Furthermore, it
would be of interest in future studies to assess the distal
nerve stump and the target organ to compare the differen-
ces in growth factors to those in the MPG. Future studies
will also be required to assess the change in growth factor
distribution in the MPGs from injured rats by immuno-
fluorescent staining.
CONCLUSIONS
Prevention of ED in men undergoing a radical prostatec-
tomy will become possible only when the molecular targets
leading to neurodegeneration and neurogenesis following
CN injury are fully understood. This study demonstrates
that neurotrophic factors, such as ATF3, GDNF, and NGF,
are significantly elevated following CN injury. Increased
neurite outgrowth is evident in 24- and 48-hr injured
MPGs, which corresponds to the increased neurotrophic
gene expression levels demonstrated after BCNI in vivo.
The prevention of neurodegeneration and promotion of
survival of axons at an early stage after nerve injury are criti-
cal. A cocktail of neurotrophic factors administered at criti-
cal time points may be required to prevent
neurodegeneration. Additional studies examining the roles
of neurotrophic factors in modulating neuroregenerative
signaling pathways may provide future therapeutic avenues
for neurogenic-mediated ED.
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